Sarah Yuan

Chief Technology Officer Cabaletta Bio

Seminars

Thursday 26th February 2026
Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe
1:30 pm
  • Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
  • Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards
Wednesday 25th February 2026
Exploring Automation to Scale Out Autologous CAR-T Manufacturing
12:30 pm
  • Examine how automation enables scalable, parallelised production of autologous CAR-T therapies without compromising quality
  • Discuss how streamlined, modular manufacturing platforms can lower costs and accelerate patient access
Sarah Yuan